Physician profile
Daniel Son
NPI 1801658604
$2,659.19
in general payments reported to CMS, 2019-2025
18 companies · $2,659 in 2025
The $2,659 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,659.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $847.93 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $314.00 | 2025 | Dupixent |
| Genzyme Corporation | $245.15 | 2025 | |
| Leo Pharma INC. | $238.02 | 2025 | Adbry, Anzupgo |
| Ucb, INC. | $203.77 | 2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $179.84 | 2025 | Cabtreo |
| Sun Pharmaceutical Industries INC. | $95.82 | 2025 | |
| Janssen Biotech, INC. | $95.45 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $85.60 | 2025 | |
| Amgen INC. | $81.32 | 2025 | Otezla |
| Lilly USA, LLC | $60.66 | 2025 | Taltz, Ebglyss |
| Incyte Corporation | $58.93 | 2025 | Opzelura |
| Pfizer INC. | $40.83 | 2025 | |
| Arcutis Biotherapeutics, INC. | $25.95 | 2025 | Zoryve |
| Mayne Pharma Commercial LLC | $25.06 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $24.03 | 2025 | Sofdra |
| Almirall LLC | $22.87 | 2025 | Klisyri |
| Verrica Pharmaceuticals INC. | $13.96 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Son listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.